Literature DB >> 32313464

Drug deprescription-withdrawal risk, prevention, and treatment.

Madison K Bangert1, Gabriel M Aisenberg1.   

Abstract

In most cases, a sudden interruption of most medications has no major consequences. There are well-recognized therapies that, when withheld, can either lead to the reappearance of the symptoms they were controlling or to signs or symptoms of withdrawal. In this article, we present a table including medications that when interrupted can produce withdrawal syndromes, the signs and symptoms of the withdrawal syndrome, the time to onset and resolution of the syndrome, information regarding alternative delivery options for the drug/s when the oral route is not possible, as well as prevention and therapy.
Copyright © 2019 Baylor University Medical Center.

Entities:  

Keywords:  Deprescriptions; patient safety; withdrawal

Year:  2019        PMID: 32313464      PMCID: PMC7155970          DOI: 10.1080/08998280.2019.1695510

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  50 in total

Review 1.  Drug withdrawal syndromes-- a literature review.

Authors:  G C Hodding; M Jann; I P Ackerman
Journal:  West J Med       Date:  1980-11

2.  Letter: Clonidine withdrawal.

Authors:  S A Cairns; A J Marshall
Journal:  Lancet       Date:  1976-02-14       Impact factor: 79.321

3.  Prescription Opioid Taper Support for Outpatients With Chronic Pain: A Randomized Controlled Trial.

Authors:  Mark D Sullivan; Judith A Turner; Cory DiLodovico; Angela D'Appollonio; Kari Stephens; Ya-Fen Chan
Journal:  J Pain       Date:  2016-11-28       Impact factor: 5.820

4.  Gabapentin abuse, and delirium tremens upon gabapentin withdrawal.

Authors:  Christopher Pittenger; Paul H Desan
Journal:  J Clin Psychiatry       Date:  2007-03       Impact factor: 4.384

5.  Topiramate in opiate withdrawal.

Authors:  Daniele F Zullino; Anne-Claude Cottier; Jacques Besson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-10       Impact factor: 5.067

6.  Gabapentin withdrawal syndrome in the presence of a taper.

Authors:  Kien T Tran; Diane Hranicky; Tracey Lark; Nj Jacob
Journal:  Bipolar Disord       Date:  2005-06       Impact factor: 6.744

7.  Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.

Authors:  F Waagstein; K Caidahl; I Wallentin; C H Bergh; A Hjalmarson
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

8.  Spasticity increases during pregabalin withdrawal.

Authors:  J J Braid; S G B Kirker; I J Baguley
Journal:  Brain Inj       Date:  2013       Impact factor: 2.311

9.  Acute myocardial infarction as a complication of clonidine withdrawal.

Authors:  John Simic; Stephen Kishineff; Richard Goldberg; William Gifford
Journal:  J Emerg Med       Date:  2003-11       Impact factor: 1.484

Review 10.  A 'crash' course on psychostimulant withdrawal as a model of depression.

Authors:  Alasdair M Barr; Athina Markou; Anthony G Phillips
Journal:  Trends Pharmacol Sci       Date:  2002-10       Impact factor: 14.819

View more
  1 in total

Review 1.  A narrative review of evidence to guide deprescribing among older adults.

Authors:  Kenya Ie; Shuichi Aoshima; Taku Yabuki; Steven M Albert
Journal:  J Gen Fam Med       Date:  2021-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.